Literature DB >> 21063804

Anti-glycolipid GM2-positive Guillain-Barre syndrome due to hepatitis E infection.

S Cronin1, R McNicholas, E Kavanagh, V Reid, K O'Rourke.   

Abstract

BACKGROUND: Hepatitis E infection is most prevalent in developing countries with poor sanitation, but can also occur apparently sporadically in more developed areas. CASE: We here report a second European case of Guillain-Barre syndrome due to hepatitis E infection in association with anti-glycolipid GM2 antibody.
INTERPRETATION: This is likely to be a specific association involving molecular mimicry, and further European cases can therefore be expected.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21063804     DOI: 10.1007/s11845-010-0635-7

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  18 in total

1.  Antibody responses in the Guillain-Barré syndrome.

Authors:  H P Hartung; R C Kieseier
Journal:  J Neurol Sci       Date:  1999-10-15       Impact factor: 3.181

2.  Guillain-Barré syndrome with acute hepatitis E.

Authors:  A Sood; V Midha; N Sood
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

3.  Seizure associated with acute hepatitis E.

Authors:  D Kejariwal; S Roy; N Sarkar
Journal:  Neurology       Date:  2001-11-27       Impact factor: 9.910

4.  Oculomotor palsy associated with hepatitis E infection.

Authors:  K K Yadav; A Rohatgi; S K Sharma; M Kulshrestha; S Sachdeva; V Pardasani
Journal:  J Assoc Physicians India       Date:  2002-05

5.  Acute transverse myelitis following hepatitis E virus infection.

Authors:  Kausik Mandal; Nidhi Chopra
Journal:  Indian Pediatr       Date:  2006-04       Impact factor: 1.411

6.  Guillain-Barre syndrome associated with acute hepatitis E.

Authors:  Praful Kamani; Rajiv Baijal; Deepak Amarapurkar; Parijat Gupte; Nikhil Patel; Praveen Kumar; Subhash Agal
Journal:  Indian J Gastroenterol       Date:  2005 Sep-Oct

7.  Demyelinating neuropathy associated with hepatitis B virus infection. Detection of immune complexes composed of hepatitis B virus surface antigen.

Authors:  N Tsukada; C S Koh; A Inoue; N Yanagisawa
Journal:  J Neurol Sci       Date:  1987-02       Impact factor: 3.181

Review 8.  Epidemiology of hepatitis E: current status.

Authors:  Rakesh Aggarwal; Sita Naik
Journal:  J Gastroenterol Hepatol       Date:  2009-08-03       Impact factor: 4.029

9.  Molecular mimicry in Guillain-Barré syndrome.

Authors:  K A Sheikh; T W Ho; I Nachamkin; C Y Li; D R Cornblath; A K Asbury; J W Griffin; G M McKhann
Journal:  Ann N Y Acad Sci       Date:  1998-06-19       Impact factor: 5.691

10.  Clinical presentation and outcome of Guillain-Barré and related syndromes in relation to anti-ganglioside antibodies.

Authors:  M Carpo; R Pedotti; S Allaria; F Lolli; S Matà; G Cavaletti; A Protti; S Pomati; G Scarlato; E Nobile-Orazio
Journal:  J Neurol Sci       Date:  1999-10-15       Impact factor: 3.181

View more
  16 in total

1.  Hepatitis E with Gullain-Barré syndrome: still a rare association.

Authors:  Bhawna Sharma; Kadam Nagpal; Raghavendra Bakki Sannegowda; Swayam Prakash
Journal:  J Neurovirol       Date:  2013-03-08       Impact factor: 2.643

2.  Guillain-Barré syndrome and encephalitis/encephalopathy of a rare case of Northern China acute severe hepatitis E infection.

Authors:  Xiao-Dong Chen; Ye-Ting Zhou; Jin-Jin Zhou; Yuan-Wei Wang; Dao-Ming Tong
Journal:  Neurol Sci       Date:  2014-04-04       Impact factor: 3.307

3.  First case of anti-ganglioside GM1-positive Guillain-Barré syndrome due to hepatitis E virus infection.

Authors:  I Maurissen; A Jeurissen; T Strauven; D Sprengers; B De Schepper
Journal:  Infection       Date:  2011-08-30       Impact factor: 3.553

Review 4.  Chronic hepatitis e virus infection and treatment.

Authors:  Nassim Kamar; Jacques Izopet; Harry R Dalton
Journal:  J Clin Exp Hepatol       Date:  2013-05-25

Review 5.  Hepatitis E virus and neurological injury.

Authors:  Harry R Dalton; Nassim Kamar; Jeroen J J van Eijk; Brendan N Mclean; Pascal Cintas; Richard P Bendall; Bart C Jacobs
Journal:  Nat Rev Neurol       Date:  2015-12-29       Impact factor: 42.937

Review 6.  Hepatitis E virus infection.

Authors:  Nassim Kamar; Harry R Dalton; Florence Abravanel; Jacques Izopet
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

Review 7.  Host immune status and response to hepatitis E virus infection.

Authors:  Lisa J Krain; Kenrad E Nelson; Alain B Labrique
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

Review 8.  Guillain-Barré syndrome, transverse myelitis and infectious diseases.

Authors:  Yhojan Rodríguez; Manuel Rojas; Yovana Pacheco; Yeny Acosta-Ampudia; Carolina Ramírez-Santana; Diana M Monsalve; M Eric Gershwin; Juan-Manuel Anaya
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

9.  Guillain-Barré and Miller Fisher syndromes in patients with anti-hepatitis E virus antibody: a hospital-based survey in Japan.

Authors:  Jiro Fukae; Jun Tsugawa; Shinji Ouma; Tomoko Umezu; Susumu Kusunoki; Yoshio Tsuboi
Journal:  Neurol Sci       Date:  2016-07-07       Impact factor: 3.307

10.  Guillain-Barré syndrome associated with autochthonous infection by hepatitis E virus subgenotype 3c.

Authors:  N Scharn; T Ganzenmueller; J J Wenzel; R Dengler; A Heim; F Wegner
Journal:  Infection       Date:  2013-03-20       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.